Nyxoah SA

Research Nyxoah SA (NYXH) on Bullrun: market cap USD 73.74M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNYXH
• ExchangeNASDAQ
• CountryBelgium
• SectorHealthcare
• IndustryMedical Instruments & Supplies
• CurrencyUSD
• Market capUSD 73.74M
• Financial periodFY2023
• RevenueEUR 4.35M
• Revenue growth41.0%
• Net income-EUR 43.21M
• Free cash flow-EUR 47.28M
• Gross margin61.9%

Valuation Snapshot

latest market cap is USD 73.74M.

About Nyxoah SA

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Frequently asked questions

What is Nyxoah SA's market cap?

Nyxoah SA's market capitalization is USD 73.74M.

What does Nyxoah SA do?

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.